Canada issues final rules on classifying products as drugs, devices

03/18/2013 | Clinica (subscription required)

Health Canada has finalized guidelines for classifying therapeutic products as drugs or devices. The guidance sheds light on the considerations for determining whether a product is a medical device or drug, and it aims to promote a standardized and transparent process when deciding the appropriate regulatory pathway. The guidance notes that a product cannot be considered both a device and a drug.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC